Shanshan Cao

981 citations
52 papers · 743 indexed · h-index 16
Topics
Particle Accelerators and Free-Electron Lasers (5 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Glycosylation and Glycoproteins Research (4 papers)

In The Last Decade

Shanshan Cao

46 papers receiving 727 citations

Peers

Shanshan Cao
Comparison fields: 5 of 104
  • Molecular Biology 398
  • Oncology 118
  • Cancer Research 109
  • Biomedical Engineering 77
  • Radiology, Nuclear Medicine and Imaging 72
Replace Fei Hua with:
Fei Hua United States
Ying Zheng China
Shang‐Rong Ji China
Zhitu Zhu China
Matthew Harris United States
Koji Yamasaki Japan
Vahe M. Zohrabian United States
Daisuke Yasuda Japan
Gusheng Tang China
Sarah A. Head United States
Shanshan Cao relative to Fei Hua United States Fei Hua's profile →
Citations per field
00.5×2.9×
Fei Hua · 1×
Citations per year

Countries citing papers authored by Shanshan Cao

Since Specialization
Citations

This map shows the geographic impact of Shanshan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanshan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanshan Cao more than expected).

Fields of papers citing papers by Shanshan Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanshan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanshan Cao. The network helps show where Shanshan Cao may publish in the future.

Co-authorship network of co-authors of Shanshan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Shanshan Cao. A scholar is included among the top collaborators of Shanshan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanshan Cao. Shanshan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 11
5 1
6 9
7 9
8 0
9 8
10 7
11 12
12 8
13 14
14 46
15 25
16 20
17 7
18 19
19 57
20 31

About Shanshan Cao

Shanshan Cao is a scholar working on Internal Medicine, Immunology and Allergy and Radiation, having authored 52 papers that have together received 743 indexed citations. Recurring topics across this work include Particle Accelerators and Free-Electron Lasers (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cancer Research (109 citations), Molecular Biology (398 citations) and Oncology (118 citations). Shanshan Cao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lei Chen, Daiming Fan, Bei Chen, Kaichun Wu, Zuoren Yu, Qian Zhao, Jinhui Lü, Jia Cui, Taidong Qiao and Aidong Wen. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026